Home/AKL Therapeutics/Dr. Nicholas Larkins
DN

Dr. Nicholas Larkins

Founder, Former Chief Research Officer (deceased)

AKL Therapeutics

Therapeutic Areas

AKL Therapeutics Pipeline

DrugIndicationPhase
APPAKnee Osteoarthritis (with moderate to severe pain and nociplastic pain features)Phase 2b